The Effect of Frog Virus 3 on the Biological Activity of various RNA Viruses
(Accepted 28 June 1973) SUMMARY Frog virus 3 inhibits the replication of various RNA viruses: nuclear and cytoplasmic, coated and uncoated, large and small. The inhibition is apparent at 37 °C, a non-permissive temperature for frog virus 3. Frog virus 3 particles must be present in the cell during the RNA replication in order to achieve inhibition. Our results indicate that the inhibition occurs in the early stages of virus replication.
Frog virus (FV-3) is a large cytoplasmic DNA virus with a wide range of host cells and special thermal requirements for growth (Granoff, t969) . Although FV-3 cannot replicate at 37 °C (Maes & Granoff, 1967; Kucera, 197o) , its presence in the infected cells causes a marked inhibition of host DNA and RNA synthesis (McAuslan & Smith, I968; Guir, Braunwald & Kirn, I971 ) . Moreover, at this non-permissive temperature, superinfection with FV-3 inhibits the synthesis of vaccinia virus DNA and RNA (Aubertin & Kirn, 1969; Aubertin, Guir & Kirn, 197o; Vilagines & McAuslan, T97o) , Sindbis virus RNA (Guir & Braunwald, I97I) and Simian virus 4 ° DNA (R. Barzilai, E. Finkelkraut, L. H. Lazarus & N. Goldblum, unpublished observations). In order to study the mechanism of inhibition of RNA synthesis by FV-3, we subjected cell cultures infected with various RNA viruses to superinfection with FV-3. The experiments below were designed to determine how varied are the RNA viruses inhibited by FV-3, the stage of the RNA virus cycle sensitive to inhibition by FV-3 and whether the inhibition caused depended on FV-3-directed synthesis.
The following viruses were employed in our experiments: influenza virus strain A2/Hong Kong/1968, Newcastle disease virus (NDV) strain E-Te, Sindbis virus strain AR-339, foot-and-mouth disease virus (FMDV) strain SAT-l, and an attenuated strain of poliovirus type I. BHK 21 cell cultures were used for the propagation of NDV, FMDV and Sindbis vints. Polio virus was grown in BSC-I cells and influenza virus in cultures of primary monkey kidney cells. FV-3 was propagated usually in BHK 21 cells (Maes & Granoff, I967) , but strains were selected for growth in BSC-I or primary monkey kidney cells so as to achieve optimal conditions for co-infection with polio virus or influenza virus, respectively. The infectivity of the viruses was measured by plaque assay, except for influenza virus which was assayed by microhaemagglutination of a o'5 % suspension of guinea-pig red blood cells (Sever, 1962 FV-3 was tested for an inhibitory effect on the growth of FMDV, Sindbis virus, polio virus and influenza virus. Sets of the appropriate cell cultures (about lO 5 cells/culture) were infected with each of these viruses at an input multiplicity of about IOO p.f.u./cell, except for influenza virus which was introduced at 5 H.A.U./culture. Parallel sets of cultures were co-infected with FV-3 at a multiplicity of Io p.f.u./cell. All cultures were incubated at 37 °C and duplicate samples were withdrawn at various times after infection. The samples were frozen at -2o °C and assayed later for plaque formation ( The same experimental design was employed for the study of the RNA synthesis directed by FMDV, Sindbis virus and NDV, under conditions of co-infection with FV-3. For these experiments cultures of BHK cells were infected with about I oo p.f.u, of each virus, including FV-3. Actinomycin D (AD, Merck, Sharp, and Dohm) was added at I #g/ml to all cultures at ~ h before infection and this level was maintained throughout the experiments. uridine (29 Ci/m-mol; The Radiochemical Centre, Amersham, U.K.) was introduced to all cultures at I #Ci/ml after 30 rain of virus adsorption. All experimental steps were carried out at 37 °C. At various times after infection, samples were withdrawn from duplicate cultures, solubilized by the addition of sodium dodecyl sulphate to a final concentration of 2 %, and precipitated with TCA. The acid-precipitable material was then filtered on to Whatman's GF/C filters, the filters were washed with acetone, dried and counted in a toluenebased scintillation fluid. Under these conditions, co-infection with FV-3 caused a marked inhibition of the RNA synthesis directed by FMDV, Sindbis virus or NDV (Fig. 3)- The observation that the replication of various viruses was inhibited by FV-3 suggested that FV-3 interfered with virus growth at an early stage. Experiments in which FV-3 was introduced at later times after the primary infection showed that the efficiency of the inhibition declined with the increase in time before superinfection.
In order to quantitate the inhibitory potential of FV-3, cultures infected withinfluenza virus were superinfected 2 h later with sequential tenfold dilutions of FV-3, to give multiplicities of IO to Io -~ p.f.u./cell. Haemagglutinating activity was measured at 48 h after infection. A 5o% inhibition was achieved by as little as ro -z to IO -~ p.f.u. FV-3/cell, thus I p.f.u, was estimated to be equivalent to at least xo 2 virus 50 % inhibitory doses (IOO VIDs0 ). This discrepancy between the infectivity and inhibitory potentials of FV-3 suggested that particles that do not register as plaque formers are nevertheless potent as inhibitors. In order to substantiate this assumption, suspensions of FV-3 were exposed to u.v. irradiation, using a Mineralite lamp (25o mA) at a distance of IO cm. Samples were withdrawn at various times and assayed for infectivity and for inhibition of influenza virus as described. It was found that the decay in infectivity was not accompanied by any decrease in the inhibitory potential.
The results presented above show that FV-3 is effective in inhibiting a number of RNA viruses of different groups. The replication of the RNA viruses is blocked at quite an early stage, probably at the onset of the virus RNA synthesis or earlier. The achievement of the observed inhibition under conditions of non-permissive temperature and in the presence of actinomycin D, suggested that this inhibition was independent of an FV-3 product made de novo. This conclusion was supported by the observation that non-infective FV-3 particles, naturally occurring or produced by u.v. irradiation, were still effective in inhibiting other viruses. Similar conclusions were inferred from experiments concerning the inhibition of vaccinia virus by heat or y-inactivated FV-3 (Aubertin et al. 2970) . The possibility that an extremely rapid induction of interferon by FV-3 was the cause of the observed inhibition was ruled out by the results obtained in experiments with actinomycin D. The active inhibitor may be, therefore, a structural component of the FV-3 virus particle (Vilagines & McAuslan, 197o ) to be found also in otherwise inactive particles. Recent findings (Aubertin & McAuslan, I972; Kang & McAuslan, I972; Palese & Koch, 1972; Palese & McAuslan, I972 ) indicate that several endonuclease activities are associated with the FV-3 virus particle. It is tempting to correlate the inhibitory activity of FV-3 with some of its associated endonuclease, and this is being studied.
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